Multimodal AI and the Future of Diagnostics
Dec 10, 2025
Health & Pharma Stage
Health & Pharma
- AI is moving beyond single data streams – fusing imaging, labs, patient records, and genomics to improve end-to-end clinical development.
- This session explores how multimodal tools are being deployed in real clinical settings to improve patient selection and biomarker development, accelerate phase 1/2 clinical trials, increase probability of success for phase 3 trials and identify combination regimens across disease landscapes.
- Hear honest assessments from frontline users: what’s working, where the tools fall short, and how they see the future evolving from their perspective.
Session Type
Presentation
Content Focus
Use Case